Factor VIII replacement therapy (Bayer product)

recombinant factor VIII · Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Factor VIII replacement therapy (Bayer product), covering 2014-12-18 to 2014-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A [Phase 4]